Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Acetic Acid | HCID 176 | — |
| Reactant | 4-Methylmorpholine | HCID 7972 | — |
| Reactant | Isobutyl chloroformate | HCID 62365 | — |
| Reactant | HCID 178510999 | HCID 178510999 | — |
| Reactant | HCID 178514039 | HCID 178514039 | — |
| Catalyst | Palladium | HCID 23938 | — |
| Solvent | Water | HCID 962 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Product | 3,5-Dioxohexanoic acid | HCID 5459844 | — |
Reaction Steps
The product was dissolved in anhydrous methanolic hydrogen chloride (saturated at 0° C.) for 30 minutes, followed by removal of solvent under reduced pressure, forming Nim -benzyloxycarbonyl-L-histidyl-glycine amide. This was dissolved in tetrahydrofuran, and isobutyl chloroformate, N-methylmorpholine, and Nα,Nε -dibenzyloxycarbonyl-L-lysyl-L-histidyl-glycine amide (3 hours at -20° C., then 1 hour at ambient temperature). This product was then dissolved in glacial acetic acid and hydrogenated overnight in the presence of 10% Pd-C catalyst. The resultant L-lysyl-L-histidyl-glycine amide was lyophilized from water several times, then purified by liquid chromatography on a C-18 reverse-phase column to yield the desired tripeptide amide as a triacetate salt.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05120831 |
|---|
| Source dataset | uspto-grants-1992_06 |
|---|
| ORD ID | ord-06ab4d23253f4af0bd0a81458e193a9f |
|---|
| Source note | uspto-grants-1992_06 |
|---|